Navigation Links
Moffitt Cancer Center signs licensing agreement with Proteacel, LLC
Date:3/18/2010

Tampa, FL (March 18, 2010) Moffitt Cancer Center and Proteacel LLC announced today that they have entered a licensing agreement under which Proteacel has acquired the exclusive rights to the PORE technology for delivery of genes into cells.

Genes are the instructions that build cells. Defects in these genes cause disease, such as cancer. In order to understand how these genes work and their involvement in a disease process, researchers must study and modify them. The most common way to study gene function is to transfer the gene into cells. Transfection is the process of introducing foreign DNA, or genes, into cells. This fundamental process is critical in conducting medical research. However, low rates of transfection and high levels of cell death currently create bottlenecks.

Under the direction of Dr. Deepak Agrawal, Moffitt researchers have developed a proprietary technology that dramatically improves the functionality and performance of transfection technology. The patented Perforation Optimization and Repair Enhancement, or PORE, solves a number of immediate problems in the use of transfection by creating a higher level of efficiency and cell viability. This is particularly valuable for stem cells and primary cells that are the most medically relevant and the most difficult to transfect.

"I am very pleased that the PORE technology will be made available to researchers throughout the world," Agrawal said. "We believe PORE will fuel biological discovery by allowing more effective use of stem cells and primary cells for research, drug discovery and development of cell therapies."

"Proteacel's initial business activity will have Proteacel contracting to transfect specific hard to transfect cell lines with identified DNA," said Dr. Joseph Zendegui, president and chief operating officer of Proteacel. "Target customers for this service will be academic institutions and biotechnology companies in the biomedical research field. Using PORE as our technology base, we will expand our efforts into development and commercialization of drug discovery, cell differentiation assays."

"We are excited to see this technology move from the research labs here at Moffitt Cancer Center into the capable hands of Proteacel for the continuation of its development," said Ray Carpenter of Moffitt's Office of Technology Management and Commercialization. "Further, our office will remain focused on bridging entrepreneurs and Moffitt's faculty to cultivate local start-up company opportunities."

Under the terms of the License Agreement, Proteacel will pay Moffitt license fees, milestone payments and royalties on sales of PORE products and services.


'/>"/>

Contact: Michelle Foley
Michelle.Foley@moffitt.org
813-745-1505
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related biology news :

1. Could regulating intestinal inflammation prevent colon cancer?
2. Blocking cancer in its path: New cellular defect discovered
3. UAB oncologists: HPV vaccine protects from cancer recurrence
4. 2 at 1 stroke -- how cells protect themselves from cancer
5. 5th Annual Szent-Györgyi Prize for Progress in Cancer Research awarded
6. A golden bullet for cancer
7. Preventing gastric cancer with antibiotics
8. Berkeley scientists find new way to get physical in the fight against cancer
9. VAI researchers develop tool to help study prostate cancer
10. LSUHSC researcher finds first inherited prostate cancer genetic mutation in African-American men
11. Breast cancer drug fulvestrant appears more effective in the presence of CK8 and CK18
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory ... technical consulting, provides a free webinar on Performing Quality Investigations: Getting ... at 12pm CT at no charge. , Incomplete investigations are still a major ...
(Date:6/23/2016)... -- Amgen (NASDAQ: AMGN ) today announced a ... sciences incubator to accelerate the development of new therapies ... QB3@953 was created to help high-potential life science and ... stage organizations - access to laboratory infrastructure. ... "Amgen Golden Ticket" awards, providing each winner with one ...
(Date:6/22/2016)... Cell Applications, Inc. and StemoniX announced ... up to one billion human induced pluripotent stem ... These high-quality, consistent stem cells enable researchers to ... more time doing meaningful, relevant research. This achievement ... process that produces affordable, reliable HiPSC for life ...
(Date:6/22/2016)... , June 22, 2016  According to Kalorama ... generation sequencing (NGS) market include significant efforts in ... sequencers.  More accessible and affordable sequencers, say the ... demand for consumables including sample prep materials.  The ... for Sample Preparation for Next Generation Sequencing (NGS) ...
Breaking Biology Technology: